Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527]
- RabMAb
- Recombinant
- 20ul selling size
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal Cyclin D1 phospho T286 antibody. Suitable for Dot, WB and reacts with Synthetic peptide - Human, Human samples.
View Alternative Names
BCL1, PRAD1, CCND1, G1/S-specific cyclin-D1, B-cell lymphoma 1 protein, BCL-1 oncogene, PRAD1 oncogene, BCL-1
- WB
Lab
Western blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (AB325926)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Performed under reducing conditions.
In Western blot, aab325926 was shown to bind specifically to Cyclin D1 (phospho T286). Target of interest was observed at 33 kDa in A549 treated with 10µM MG-132 for 4 hours lysates (lane 2) with no signal observed at this size in CCND1 (Cyclin D1) knockout cell line (lanes 3-4) (lanes 3-4, knockout cell line ab286759).
The identity of the bands higher than 75kda are unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).
All lanes:
Western blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (ab325926) at 1/1000 dilution
Lane 1:
Untreated A549 (human lung carcinoma epithelial cell) whole cell lysate 20 µg (untreated membrane)
Lane 2:
A549 treated with 10µM MG-132 for 4 hours whole cell lysate 20 µg (untreated membrane)
Lane 3:
Untreated CCND1 (Cyclin D1) knockout A549 whole cell lysate 20 µg (untreated membrane)
Lane 4:
CCND1 (Cyclin D1) knockout A549 treated with 10µM MG-132 for 4 hours whole cell lysate 20 µg (untreated membrane)
Lane 5:
Untreated A549 (human lung carcinoma epithelial cell) whole cell lysate 20 µg (alkaline phosphatase treated membrane)
Lane 6:
A549 treated with 10µM MG-132 for 4 hours whole cell lysate 20 µg (alkaline phosphatase treated membrane)
Lane 7:
Untreated CCND1 (Cyclin D1) knockout A549 whole cell lysate 20 µg (alkaline phosphatase treated membrane)
Lane 8:
CCND1 (Cyclin D1) knockout A549 treated with 10µM MG-132 for 4 hours whole cell lysate 20 µg (alkaline phosphatase treated membrane)
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 33 kDa,36 kDa
false
Exposure time: 48s
- WB
Lab
Western blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (AB325926)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).
All lanes:
Western blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (ab325926) at 1/1000 dilution
Lane 1:
Untreated HT-1080 (human fibrosarcoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HT-1080 treated with 10µM MG-132 for 4 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 33 kDa,36 kDa
false
Exposure time: 92s
- Dot
Lab
Dot Blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (AB325926)
Dot blot analysis of Cyclin D1 using ab325926 at 1 : 10000 (0.051 µg/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
Lane 1 : Human Cyclin D1 (phospho T286) peptide
Lane 2 : Human Cyclin D1 (non-phospho) peptide
Lane 3 : Human Cyclin D2 (phospho T280) peptide
Lane 4 : Human Cyclin D3 (phospho T283) peptide
Exposure time : 180 seconds.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The antibody recognises CCND1 (Cyclin D1) when phosphorylated at Threonine 286, and shows weak reactivity with CCND2 (Cyclin D2) when phosphorylated at Threonine 280 by dot blot.
All lanes:
Dot Blot - Anti-Cyclin D1 (phospho T286) antibody [EPR30260-527] (ab325926) at 1/10000 dilution
Lane 1:
Human Cyclin D1 (phospho T286) peptide
Lane 2:
Human Cyclin D1 (non-phospho) peptide
Lane 3:
Human Cyclin D2 (phospho T280) peptide
Lane 4:
Human Cyclin D3 (phospho T283) peptide
Secondary
All lanes:
Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 180s
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com